Absci Corporation (ABSI)
$1.41
+0.12 (+9.30%)
Rating:
Recommendation:
-
| Symbol | ABSI |
|---|---|
| Price | $1.41 |
| Beta | 1.231 |
| Volume Avg. | 0.42M |
| Market Cap | 130.723M |
| Shares () | - |
| 52 Week Range | 1.13-3.71 |
| 1y Target Est | - |
| DCF Unlevered | ABSI DCF -> | |
|---|---|---|
| DCF Levered | ABSI LDCF -> | |
| ROE | -43.12% | Strong Sell |
| ROA | -43.97% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 9.04% | Neutral |
| P/E | -1.17 | Sell |
| P/B | 0.60 | Buy |
Latest ABSI news
About
Download (Excel)Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.